153 related articles for article (PubMed ID: 3856890)
1. Alkylating agent resistance: in vitro studies with human cell lines.
Frei E; Cucchi CA; Rosowsky A; Tantravahi R; Bernal S; Ervin TJ; Ruprecht RM; Haseltine WA
Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2158-62. PubMed ID: 3856890
[TBL] [Abstract][Full Text] [Related]
2. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
[TBL] [Abstract][Full Text] [Related]
3. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
4. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
Aida T; Bodell WJ
Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016
[TBL] [Abstract][Full Text] [Related]
5. Preclinical studies and clinical correlation of the effect of alkylating dose.
Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
[TBL] [Abstract][Full Text] [Related]
6. Theophylline does not reverse DNA replicon initiation inhibition in human cells resistant to alkylating agent-theophylline killing synergism.
Ducore JM; Rosenstein BS
Chem Biol Interact; 1984 Sep; 51(2):191-200. PubMed ID: 6540627
[TBL] [Abstract][Full Text] [Related]
7. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
8. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
Aida T; Bodell WJ
No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
[TBL] [Abstract][Full Text] [Related]
9. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts.
Goldenberg GJ
Cancer Res; 1975 Jul; 35(7):1687-92. PubMed ID: 1055634
[TBL] [Abstract][Full Text] [Related]
10. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
[TBL] [Abstract][Full Text] [Related]
11. Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence.
Frei E; Ara G; Teicher B; Bunnell C; Richardson P; Wheeler C; Tew K; Elias A
Cancer Chemother Pharmacol; 2000; 45(3):239-46. PubMed ID: 10663642
[TBL] [Abstract][Full Text] [Related]
12. Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies.
Frei E; Holden SA; Gonin R; Waxman DJ; Teicher BA
Cancer Chemother Pharmacol; 1993; 33(2):113-22. PubMed ID: 8261570
[TBL] [Abstract][Full Text] [Related]
13. Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells.
Tan KB; Mattern MR; Boyce RA; Hertzberg RP; Schein PS
NCI Monogr; 1987; (4):95-8. PubMed ID: 2819739
[TBL] [Abstract][Full Text] [Related]
14. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
[TBL] [Abstract][Full Text] [Related]
15. Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.
Tan KB; Mattern MR; Boyce RA; Schein PS
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7668-71. PubMed ID: 2823270
[TBL] [Abstract][Full Text] [Related]
16. DNA interstrand crosslinking and strand break repair in human glioma cell lines of varying [1,3-bis(2-chloroethyl)-1-nitrosourea] resistance.
Ali-Osman F; Srivenugopal K; Berger MS; Stein DE
Anticancer Res; 1990; 10(3):677-82. PubMed ID: 2164350
[TBL] [Abstract][Full Text] [Related]
17. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E
Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117
[TBL] [Abstract][Full Text] [Related]
18. The contribution of alkylation to the activity of quinone antitumor agents.
Begleiter A
Can J Physiol Pharmacol; 1986 May; 64(5):581-5. PubMed ID: 3730943
[TBL] [Abstract][Full Text] [Related]
19. Effect of alpha-difluoromethylornithine on 1,3-bis(2-chloroethyl)-1-nitrosourea and cis-diamminedichloroplatinum(II) cytotoxicity, DNA interstrand cross-linking, and growth in human brain tumor cell lines in vitro.
Hunter KJ; Deen DF; Pellarin M; Marton LJ
Cancer Res; 1990 May; 50(9):2769-72. PubMed ID: 2109657
[TBL] [Abstract][Full Text] [Related]
20. Decreased DNA interstrand cross-linking and cytotoxicity induced in human brain tumor cells by 1,3-bis(2-chloroethyl)-1-nitrosourea after in vitro reaction with glutathione.
Ali-Osman F; Caughlan J; Gray GS
Cancer Res; 1989 Nov; 49(21):5954-8. PubMed ID: 2551496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
